Document is current
Any future updates will be listed below
-
Authors
Herrera-Restrepo, Oscar https://orcid.org/0000-0001-8193-999X
Jutlla, Ginita https://orcid.org/0000-0001-6065-8574
Graham, Jonathan https://orcid.org/0000-0002-3227-5928
Carrico, Justin https://orcid.org/0000-0002-4659-9309
Grace, Mei https://orcid.org/0009-0008-3862-8203
Kocaata, Zeki https://orcid.org/0000-0002-5231-3389
Clements, Diana E. https://orcid.org/0000-0002-2410-8951
Burman, Cindy https://orcid.org/0009-0000-2860-1500
Andani, Anar https://orcid.org/0000-0003-0530-5340
Shah, Hiral https://orcid.org/0000-0003-0204-451X
-
Funding
Funding for this research was provided by:
GlaxoSmithKline Biologicals (VEO-001202)
- License Information
-
More Information
Article History
Received: 22 August 2025
Accepted: 27 January 2026
First Online: 6 March 2026
Declarations
:
: OHR is employed by and holds financial equities in GSK; GJ received consulting fees from GSK; JG is employed by RTI Health Solutions, which was paid by GSK to conduct this study; JC is employed by and holds financial equities in GSK; MG is employed by RTI Health Solutions, which was paid by GSK to conduct this study; ZK is employed by and holds financial equities in GSK; DEC is employed by and held financial equities in GSK at the time of the study and is now employed by Johnson & Johnson; CB is employed by GSK and holds financial equities in GSK and Pfizer; AA is employed by and holds financial equities in GSK; and HS is employed by and holds financial equities in GSK.
: The data generated during and/or analyzed during the current study are available within the paper and its Supplementary Information. Additional data may be requested from the corresponding author, as reasonable.
: Substantial contributions to study conception and design: OHR, GJ, JG, ZK, DEC, CB, and HS; substantial contributions to analysis and interpretation of the data: OHR, GJ, JG, JC, MG, ZK, DEC, CB, AA, and HS; drafting the article or revising it critically for important intellectual content: OHR, GJ, JG, JC, MG, ZK, DEC, CB, AA, and HS; and final approval of the version of the article to be published: OHR, GJ, JG, JC, MG, ZK, DEC, CB, AA, and HS.
